A molecule from gut bacteria reduces effect of diabetes medication

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
The action of metformin, the classic drug used to treat diabetes by stabilizing blood sugar, can be blocked by a molecule from the bacteria in our intestines, a University of Gothenburg study shows.

Metformin is the primary treatment option for type 2 diabetes, but there are major variations in how individuals respond to this drug. In some people it lowers blood glucose (sugar) and delays the course of the disease, while in others its effects are less favorable.

An article published in the journal Cell Metabolism now clarifies one underlying factor that explain why metformin action can be blocked. This blocking is preceded by processes in the gut bacteria -- the intestinal microbiota -- in which the molecule imidazole propionate is produced.

The change in gut microbiota associated with type 2 diabetes has been demonstrated in previous research under the leadership of Fredrik Backhed, Professor of Molecular Medicine at Sahlgrenska Academy, University of Gothenburg.

 
Sounds like something a day of Picolax would fix. Mind you, giving Picolax to mice would be cruel. They poop everywhere at the best of times.
 
Status
Not open for further replies.
Back
Top